Riboflavin Market Share

Statistics for the 2023 & 2024 Riboflavin market share, created by Mordor Intelligence™ Industry Reports. Riboflavin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Riboflavin Industry

The global riboflavin market is concentrated in nature due to many regional and domestic players. Importance is given to partnerships, expansions, product innovations, and mergers and acquisitions as leading companies adopt strategic approaches to boost their brand presence among consumers.

Consumers in the market are increasingly becoming health conscious and looking for health supplements. This factor strategically makes companies innovate and expand their existing product portfolios, thereby making the market more conducive to further development to gain more revenue.

Some major players in the market studied include BASF SE, Hubei Guangji Pharmaceutical Co. Ltd, Xinfa Pharmaceutical Co. Ltd, Koninklijke DSM NV, and Shanghai Acebright Pharmaceuticals Group Co. Ltd, among others.

Riboflavin Market Leaders

  1. BASF SE

  2. Hubei Guangji Pharmaceutical Co. Ltd.

  3. Koninklijke DSM NV ​

  4. Shanghai Acebright Pharmaceuticals Group Co. Ltd​.

  5. Xinfa Pharmaceutical Co. Ltd​.

*Disclaimer: Major Players sorted in no particular order

Riboflavin Market Concentration

Riboflavin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)